Posted on 6/6/17
Pfizer Makes Its Presence Known In Lung Cancer
Tagrisso has been a pleasant surprise for Astrazeneca (NYSE:AZN), outperforming initial expectations thanks in part to withdrawal of its rival Clovis Oncology (NASDAQ:CLVS) from the EGFR-positive . . .
Posted on 6/6/17
Merck's (MRK) Management Presents at Investor Briefing at 2017 ASCO Annual Meeting Conference (Transcript)
Merck & Co Inc. (NYSE:MRK)Investor Briefing at 2017 ASCO Annual Meeting CallJune 5, 2017 18:45 ETExecutivesTeri Loxam - Investor RelationsRoger Perlmutter - President, Merck Research LabsFrank . . .
Posted on 6/6/17
3 Biotech Stocks to Buy If You've Never Bought a Biotech Stock
If you don't have biotech stocks in your investing portfolio, why not? For many people, the answer is that they think biotech stocks are too risky. . . .
Posted on 6/6/17
2bPrecise Collaborates with Mayo Clinic
PITTSBURGH--(BUSINESS WIRE)--2bPrecise, LLC, an EHR-agnostic, cloud-based precision medicine platform, today announced a technology license agreement with Mayo Clinic as well as a collaboration to develop and . . .
Posted on 6/6/17
Global Strategy to End Clubfoot Disability 2030 Launched on World Clubfoot Day
Today on World Clubfoot Day, CURE International, along with its partners in the Global Clubfoot Initiative, launched a bold strategy with a vision of a world . . .
Posted on 6/5/17
3 Biotech Stocks to Buy If You've Never Bought a Biotech Stock
If you don't have biotech stocks in your investing portfolio, why not? For many people, the answer is that they think biotech stocks are too risky. . . .
Posted on 6/3/17
Health Partners Plans Launches Community-Focused Program to Promote Wellness among Southeastern PA Families
Novel approach to wellness connects the dots between improved health and access to fitness for communitiesHealth Partners Plans (HPP) is encouraging Southeastern Pennsylvanians to get up . . .
Posted on 6/2/17
Merck Wows Investors With Stellar Q1 Performance
Merck (NYSE:MRK) is one of those very few companies that has not only reported strong financial performance in Q1 2017 but also raised its 2017 revenue . . .
Posted on 6/2/17
Celgene Defends The Stock With Positive Portents
Celgene (NASDAQ:CELG) fights the sell-offThis CEO performance shows that CELG has my sort of management team. That's in contrast to the CEO of a different biotech . . .
Posted on 6/1/17
Oncobiologics Closes on Final Portion of $15 Million Senior Secured Note and Warrant Offering
CRANBURY, N.J., June 01, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex monoclonal antibody (mAb) . . .
Posted on 6/2/17
Anexinet Unveils New Mobile Customer Self-Service Platform
Anexinet Corporation, a leading provider of digital, analytics and hybrid IT solutions, today announced its Mobile Customer Self-Service (MCSS) development platform. The new offering gives organizations . . .
Posted on 6/1/17
Celgene's (CELG) CEO Mark Alles Presents at Sanford C. Bernstein Strategic Decisions Conference 2017 (Transcript)
Celgene Corporation (NASDAQ:CELG)Sanford C. Bernstein Strategic Decisions Conference 2017May 31, 2017 04:00 PM ETExecutivesMark Alles - Chief Executive OfficerAnalystsRonny Gal - Sanford C. BernsteinRonny GalThank you . . .
Posted on 6/1/17
Merck: An Approval Like No Other
Merck (NYSE:MRK) got an unusual approval at the FDA recently, for its Keytruda antibody in oncology. What’s new about it is that it is the first . . .
Posted on 6/1/17
Celgene's Stock May Be Incredibly Overvalued Right Now -- Here's Why
Celgene (NASDAQ:CELG) has long garnered one of the richest valuations among large-cap biotechs, and for good reason. The long and short of it is that Celgene . . .
Posted on 6/1/17
Cidara Therapeutics Joins SAFE-BioPharma Association
TENAFLY, N.J.--(BUSINESS WIRE)--SAFE-BioPharma Association, the non-profit coalition of biopharmaceutical companies that developed and manages the global SAFE-BioPharma® digital identity management and digital signature standards, today announced . . .
Posted on 5/30/17
EastGate Biotech's Recent Acquisition, OMNI Surgery + Anti-Aging Centre, Presents the OMNI School of Medical Esthetics
EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company that focuses on innovative pharmaceutical developments and produces and distributes innovative and healthy nutraceuticals based on . . .
Posted on 5/30/17
Wistar’s New Biomedical Research Technician Training Program Obtains First State Approval as Non-Traditional Apprenticeship
Dr. William Wunner, Wistar Director of Outreach Education and Technology Training and Director of Academic Affairs, presents a certificate from the Pennsylvania Department of Labor & . . .
Posted on 5/30/17
Does Cognizant Technology Fit the Bill as Buffett's Ideal Business?
IMAGE SOURCE: THE MOTLEY FOOL.At Berkshire Hathaway's (NYSE:BRK-B) annual meeting earlier this month, an investor asked Warren Buffett about the company's shift from investing in high-return, . . .
Posted on 5/30/17
Better Buy: Celgene Corporation vs. Bristol-Myers Squibb
Investors haven't been too enamored with Celgene (NASDAQ:CELG) and Bristol-Myers Squibb (NYSE:BMY) lately. Both have super-successful cancer drugs and are making plenty of money. However, neither . . .
Posted on 5/30/17
So Merck Just Made History. Should You Care As An Investor?
The immune checkpoint inhibitors have created a fast-running revolution in the world of cancer research. Now, there are 5 agents in the broader class of "PD-1/PD-L1" . . .
Posted on 5/30/17
3 Top Dividend Stocks in Generic Drugs
There haven't been too many positive developments in prescription drug price trends. However, there is at least one: Generic drugs now make up nearly eight out . . .
Posted on 5/30/17
Spark Therapeutics: The Next Big Thing In Gene Therapy?
Spark Therapeutics (NASDAQ:ONCE) may be a household name in gene therapy if the Food and Drug Administration's (FDA) approves its new therapy for an inherited retinal . . .
Posted on 5/30/17
Spark Therapeutics: Upcoming FDA Catalyst
One promising aspect of the future of healthcare is gene therapy. Gene therapy corrects genetic disorders by transplanting normal genes into cells in place of missing . . .
Posted on 5/30/17
GlaxoSmithKline's New CEO Is Off to a Good Start
Sir Andrew Witty's last quarter as CEO of GlaxoSmithKline plc (NYSE:GSK) produced positive results, and incoming leader Emma Walmsley gave some clues as to how things . . .
Posted on 5/30/17
Johnson & Johnson's Analyst Day Was Overshadowed by This Worrisome Data
Healthcare conglomerate Johnson & Johnson (NYSE:JNJ) is a common holding in long-term investors' portfolios for one reason: its consistency.Johnson & Johnson's consistency derives from its business . . .

